ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

EPRX Eupraxia Pharmaceuticals Inc

3,94
0,22 (5,91%)
03 Mai 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Eupraxia Pharmaceuticals Inc EPRX Toronto Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
0,22 5,91% 3,94 16:59:58
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
3,76 3,76 3,98 3,94 3,72
mais cotações »

Notícias Recentes

Data Hora Fonte Título
02/05/202408:00PRNUSEupraxia Pharmaceuticals Announces Gastrointestinal Clinical..
11/04/202408:00PRNUSEupraxia Pharmaceuticals Announces Upcoming Presentations at..
08/04/202408:00PRNCAEupraxia Pharmaceuticals To Present at Bloom Burton & Co...
05/04/202408:00PRNUSEupraxia Pharmaceuticals Begins Trading on Nasdaq Today
03/04/202418:00PRNCAEupraxia Pharmaceuticals to Begin Trading on Nasdaq on April..
01/04/202418:01PRNCAEupraxia Pharmaceuticals Reports Fourth Quarter and 2023..
15/03/202409:26GLOBEEupraxia Pharmaceuticals Announces Closing of Overnight..
12/03/202410:41PRNCAL'Organisme canadien de réglementation des investissements..
12/03/202410:39PRNCACanadian Investment Regulatory Organization Trade Resumption..
12/03/202410:31GLOBEEupraxia Pharmaceuticals Announces Pricing of Overnight..
11/03/202417:08GLOBEEupraxia Pharmaceuticals Announces Overnight Marketed..
11/03/202417:06PRNCASuspension de la négociation par l'Organisme canadien de..
11/03/202417:04PRNCACanadian Investment Regulatory Organization Trading Halt -..
05/02/202419:00PRNCAEupraxia Pharmaceuticals Announces Updated Positive Clinical..
01/02/202409:00PRNCAEupraxia Pharmaceuticals Initiates Phase 3 Development..
30/01/202409:00PRNCAEupraxia Pharmaceuticals Announces Positive Data from MRI..
08/01/202420:44PRNCAEupraxia Pharmaceuticals Announces Filing of Preliminary..
12/12/202309:00PRNCAEupraxia Pharmaceuticals Announces Positive Clinical Data in..
11/12/202309:00PRNCAEupraxia Pharmaceuticals Announces Clinical and Corporate..
14/11/202319:01PRNCAEupraxia Pharmaceuticals Reports Third Quarter 2023..
01/11/202308:00PRNCAEupraxia Pharmaceuticals to Present at the 2023 Annual..
11/10/202308:00PRNCAEupraxia Pharmaceuticals Announces Initiation of Second..
11/09/202316:32PRNCAEupraxia Pharmaceuticals to Present at the H.C. Wainwright..
07/09/202318:00PRNCAEupraxia Pharmaceuticals Announces Change of Auditor
06/09/202318:00PRNCAEupraxia Pharmaceuticals Announces Presentation at PAINWeek..
18/08/202320:20PRNCAEupraxia Pharmaceuticals Announces Closing of Non-Brokered..
11/08/202318:00PRNCAEupraxia Pharmaceuticals Reports Second Quarter 2023..
04/08/202308:00PRNCAEupraxia Pharmaceuticals Announces a Non-Brokered Private..
26/06/202308:00PRNUSEupraxia Pharmaceuticals Reports Positive Topline Data in..
15/06/202319:42PRNCAEupraxia Pharmaceuticals Announces Filing of Preliminary..
13/06/202312:04DJNEupraxia Shares Climb After FDA Fast-Track Designation for..
13/06/202308:43DJNEupraxia Pharmaceuticals Gets FDA Fast-Track Designation for..
13/06/202308:00PRNCAEupraxia Pharmaceuticals Receives U.S. FDA Fast Track..
08/06/202308:00PRNCAEupraxia Pharmaceuticals Doses First Patient in Phase 1b/2a..
25/05/202308:00PRNCAEupraxia Pharmaceuticals Announces Last Patient Last Visit..
18/05/202308:00PRNCAEupraxia Pharmaceuticals Announces Appointment of Dr. Mark..
11/05/202308:00PRNCAEupraxia Pharmaceuticals Reports First Quarter 2023..

Seu Histórico Recente

Delayed Upgrade Clock